{"id":29837,"date":"2018-12-07T11:59:06","date_gmt":"2018-12-07T10:59:06","guid":{"rendered":"https:\/\/www.anchormc.se\/serialization-in-the-pharmaceutical-industry-part-2\/"},"modified":"2018-12-07T11:59:06","modified_gmt":"2018-12-07T10:59:06","slug":"serialization-in-the-pharmaceutical-industry-part-2","status":"publish","type":"post","link":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/","title":{"rendered":"Serialization in the pharmaceutical industry part 2"},"content":{"rendered":"<p>The first challenge I\u2019ll address is: Who should bear <strong>the cost<\/strong>? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather, it\u2019s a negotiation between the drug manufacturer and its partners regarding how to allocate the additional cost resulting from this new regulatory framework. This may mean that the manufacturer needs to adjust its prices, which would lead to adjustments at every stage all the way to the user\/patient. This could be difficult, as there are likely already existing contracts in place. I think we should look at how to streamline information management to keep costs down. This could become a competitive advantage over others.     <\/p>\n<p>The next challenge is <strong>handling the <\/strong>additional information required <strong>by <\/strong>the regulations! By \u201chandling,\u201d I mean <strong>creating<\/strong>, <strong>sending<\/strong>, <strong>receiving<\/strong>, <strong>storing, and <\/strong> <strong>tracking<\/strong>. <\/p>\n<p>In this context, <strong>\u201ccreating\u201d means <\/strong>both reusing existing information and, for the vast majority of people, creating new information. One example of this is creating a unique ID on each medication package, consisting of a combination of the NDC (National Drug Code) and a unique serial number. This must be printed on each individual package; more on this later.<br \/>\nThere must also be a solution that tracks which packages are packed into larger containers at all levels up to the level at which shipping takes place.  <\/p>\n<p>As I mentioned above, more information needs to be included on medication packaging, and that could mean anything from redesigning labels to even having to use larger packages.<\/p>\n<p><strong>Sending the information involves <\/strong>first compiling all the information required by the regulations and then creating the documents where they belong\u2014that is, in TI, TS, and TH. The medium used to send this information must be agreed upon by the parties involved in the information transfer. The recipient must be able <strong>to receive these <\/strong>documents in this format. Should they be in paper form or an electronic format (such as EDI or RFID)? Different documents may be transmitted via different media if the parties agree to this. This also includes the requirement that the information must <strong>be stored for <\/strong>at least six years.      <\/p>\n<p><strong>Tracking <\/strong>, therefore, <strong>requires <\/strong>access to all of this information. With high transaction volumes, this can amount to a considerable amount of data. But that\u2019s not all\u2014a robust architecture and effective reports are also needed. So storing this information on paper is not ideal. Naturally, a digital solution is needed.    <\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first challenge I\u2019ll address is: Who should bear the cost? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather, it\u2019s a negotiation between the drug manufacturer and its partners regarding how to allocate the additional cost resulting from this new regulatory framework. This may mean that the [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":21453,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[10,23,63],"tags":[],"class_list":["post-29837","post","type-post","status-publish","has-post-thumbnail","hentry","category-artiklar","category-affars-och-verksamhetsutveckling","category-life-science"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Serialization in the pharmaceutical industry part 2 | Anchor Management Consulting<\/title>\n<meta name=\"description\" content=\"The first challenge I\u2019ll address is: Who should bear the cost? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather,\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Serialization in the pharmaceutical industry part 2\" \/>\n<meta property=\"og:description\" content=\"The first challenge I\u2019ll address is: Who should bear the cost? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Anchor Management Consulting\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/anchormc.se\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-07T10:59:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anchormc.se\/wp-content\/uploads\/3a5846be.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"778\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sven-Erik Andersson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sven-Erik Andersson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/\"},\"author\":{\"name\":\"Sven-Erik Andersson\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#\\\/schema\\\/person\\\/c97263bfd012ee1af302c8295d2d1e15\"},\"headline\":\"Serialization in the pharmaceutical industry part 2\",\"datePublished\":\"2018-12-07T10:59:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/\"},\"wordCount\":411,\"publisher\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.anchormc.se\\\/wp-content\\\/uploads\\\/3a5846be.jpg\",\"articleSection\":[\"Artiklar\",\"Aff\u00e4rs- och verksamhetsutveckling\",\"Life Science\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/\",\"url\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/\",\"name\":\"Serialization in the pharmaceutical industry part 2 | Anchor Management Consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.anchormc.se\\\/wp-content\\\/uploads\\\/3a5846be.jpg\",\"datePublished\":\"2018-12-07T10:59:06+00:00\",\"description\":\"The first challenge I\u2019ll address is: Who should bear the cost? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather,\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.anchormc.se\\\/wp-content\\\/uploads\\\/3a5846be.jpg\",\"contentUrl\":\"https:\\\/\\\/www.anchormc.se\\\/wp-content\\\/uploads\\\/3a5846be.jpg\",\"width\":1600,\"height\":778},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/serialization-in-the-pharmaceutical-industry-part-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Serialization in the pharmaceutical industry part 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#website\",\"url\":\"https:\\\/\\\/www.anchormc.se\\\/\",\"name\":\"Anchor Management Consulting\",\"description\":\"Vi hj\u00e4lper f\u00f6retag att bli framg\u00e5ngsrika\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#organization\"},\"alternateName\":\"Anchor\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.anchormc.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#organization\",\"name\":\"Anchor Management Consulting\",\"alternateName\":\"Anchor\",\"url\":\"https:\\\/\\\/www.anchormc.se\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.anchormc.se\\\/wp-content\\\/uploads\\\/anchor_mark_red_495.jpg\",\"contentUrl\":\"https:\\\/\\\/www.anchormc.se\\\/wp-content\\\/uploads\\\/anchor_mark_red_495.jpg\",\"width\":495,\"height\":498,\"caption\":\"Anchor Management Consulting\"},\"image\":{\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/anchormc.se\\\/\",\"https:\\\/\\\/www.instagram.com\\\/anchor_mc\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/anchormc\\\/\"],\"description\":\"V\u00e5r aff\u00e4rsid\u00e9 \u00e4r att driva aff\u00e4rs- och verksamhetsutveckling f\u00f6r kunder som vill ligga i framkant. F\u00f6retags utmaningar \u00e4r k\u00e4rnan i v\u00e5rt erbjudande och styr utvecklingen av v\u00e5r f\u00f6rm\u00e5ga.\",\"email\":\"hello@anchormc.se\",\"telephone\":\"+46 8 698 09 00\",\"legalName\":\"Anchor Managment Consulting AB\",\"foundingDate\":\"2007-06-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"11\",\"maxValue\":\"50\"},\"ethicsPolicy\":\"https:\\\/\\\/www.anchormc.se\\\/integritetspolicy\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.anchormc.se\\\/#\\\/schema\\\/person\\\/c97263bfd012ee1af302c8295d2d1e15\",\"name\":\"Sven-Erik Andersson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g\",\"caption\":\"Sven-Erik Andersson\"},\"description\":\"\u00bbJag arbetar huvudsakligen inom aff\u00e4rsprocessledning f\u00f6r logistik- och service-processer. Jag hj\u00e4lper v\u00e5ra kunder att f\u00f6rb\u00e4ttra deras aff\u00e4rsprocesser genom att st\u00f6tta hela v\u00e4gen fr\u00e5n utveckling av strategi, plannera f\u00f6r\u00e4ndringen, genomf\u00f6randet till att m\u00e4ta resultatet. Jag har jobbat med detta under 20 \u00e5rs tid och har mycket djup kunskap i ERP-systemet SAP.\u00ab\",\"url\":\"https:\\\/\\\/www.anchormc.se\\\/en\\\/author\\\/svenerikandersson\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Serialization in the pharmaceutical industry part 2 | Anchor Management Consulting","description":"The first challenge I\u2019ll address is: Who should bear the cost? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather,","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/","og_locale":"en_US","og_type":"article","og_title":"Serialization in the pharmaceutical industry part 2","og_description":"The first challenge I\u2019ll address is: Who should bear the cost? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather,","og_url":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/","og_site_name":"Anchor Management Consulting","article_publisher":"https:\/\/www.facebook.com\/anchormc.se\/","article_published_time":"2018-12-07T10:59:06+00:00","og_image":[{"width":1600,"height":778,"url":"https:\/\/www.anchormc.se\/wp-content\/uploads\/3a5846be.jpg","type":"image\/jpeg"}],"author":"Sven-Erik Andersson","twitter_misc":{"Written by":"Sven-Erik Andersson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/#article","isPartOf":{"@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/"},"author":{"name":"Sven-Erik Andersson","@id":"https:\/\/www.anchormc.se\/#\/schema\/person\/c97263bfd012ee1af302c8295d2d1e15"},"headline":"Serialization in the pharmaceutical industry part 2","datePublished":"2018-12-07T10:59:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/"},"wordCount":411,"publisher":{"@id":"https:\/\/www.anchormc.se\/#organization"},"image":{"@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anchormc.se\/wp-content\/uploads\/3a5846be.jpg","articleSection":["Artiklar","Aff\u00e4rs- och verksamhetsutveckling","Life Science"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/","url":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/","name":"Serialization in the pharmaceutical industry part 2 | Anchor Management Consulting","isPartOf":{"@id":"https:\/\/www.anchormc.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/#primaryimage"},"image":{"@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anchormc.se\/wp-content\/uploads\/3a5846be.jpg","datePublished":"2018-12-07T10:59:06+00:00","description":"The first challenge I\u2019ll address is: Who should bear the cost? I already hinted at this in the first article\u2026 There is no hard-and-fast rule here; rather,","breadcrumb":{"@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/#primaryimage","url":"https:\/\/www.anchormc.se\/wp-content\/uploads\/3a5846be.jpg","contentUrl":"https:\/\/www.anchormc.se\/wp-content\/uploads\/3a5846be.jpg","width":1600,"height":778},{"@type":"BreadcrumbList","@id":"https:\/\/www.anchormc.se\/en\/serialization-in-the-pharmaceutical-industry-part-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/www.anchormc.se\/en\/"},{"@type":"ListItem","position":2,"name":"Serialization in the pharmaceutical industry part 2"}]},{"@type":"WebSite","@id":"https:\/\/www.anchormc.se\/#website","url":"https:\/\/www.anchormc.se\/","name":"Anchor Management Consulting","description":"Vi hj\u00e4lper f\u00f6retag att bli framg\u00e5ngsrika","publisher":{"@id":"https:\/\/www.anchormc.se\/#organization"},"alternateName":"Anchor","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anchormc.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anchormc.se\/#organization","name":"Anchor Management Consulting","alternateName":"Anchor","url":"https:\/\/www.anchormc.se\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anchormc.se\/#\/schema\/logo\/image\/","url":"https:\/\/www.anchormc.se\/wp-content\/uploads\/anchor_mark_red_495.jpg","contentUrl":"https:\/\/www.anchormc.se\/wp-content\/uploads\/anchor_mark_red_495.jpg","width":495,"height":498,"caption":"Anchor Management Consulting"},"image":{"@id":"https:\/\/www.anchormc.se\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/anchormc.se\/","https:\/\/www.instagram.com\/anchor_mc\/","https:\/\/www.linkedin.com\/company\/anchormc\/"],"description":"V\u00e5r aff\u00e4rsid\u00e9 \u00e4r att driva aff\u00e4rs- och verksamhetsutveckling f\u00f6r kunder som vill ligga i framkant. F\u00f6retags utmaningar \u00e4r k\u00e4rnan i v\u00e5rt erbjudande och styr utvecklingen av v\u00e5r f\u00f6rm\u00e5ga.","email":"hello@anchormc.se","telephone":"+46 8 698 09 00","legalName":"Anchor Managment Consulting AB","foundingDate":"2007-06-01","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"11","maxValue":"50"},"ethicsPolicy":"https:\/\/www.anchormc.se\/integritetspolicy\/"},{"@type":"Person","@id":"https:\/\/www.anchormc.se\/#\/schema\/person\/c97263bfd012ee1af302c8295d2d1e15","name":"Sven-Erik Andersson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e69898962f89a38f90d093df62a64183025a961d66db4bd27213b91e09a29d57?s=96&d=mm&r=g","caption":"Sven-Erik Andersson"},"description":"\u00bbJag arbetar huvudsakligen inom aff\u00e4rsprocessledning f\u00f6r logistik- och service-processer. Jag hj\u00e4lper v\u00e5ra kunder att f\u00f6rb\u00e4ttra deras aff\u00e4rsprocesser genom att st\u00f6tta hela v\u00e4gen fr\u00e5n utveckling av strategi, plannera f\u00f6r\u00e4ndringen, genomf\u00f6randet till att m\u00e4ta resultatet. Jag har jobbat med detta under 20 \u00e5rs tid och har mycket djup kunskap i ERP-systemet SAP.\u00ab","url":"https:\/\/www.anchormc.se\/en\/author\/svenerikandersson\/"}]}},"_links":{"self":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/posts\/29837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/comments?post=29837"}],"version-history":[{"count":0,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/posts\/29837\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/media\/21453"}],"wp:attachment":[{"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/media?parent=29837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/categories?post=29837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.anchormc.se\/en\/wp-json\/wp\/v2\/tags?post=29837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}